Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2SiaryX
via IFTTT